2012 © Institute for Molecular Medicine Finland FIMM
SPECIAL FIMM SEMINAR given by Thomas Helleday
Monday 31. October 14:00 -
Monday 31. October 2011 15:00
Location: Lecture Hall 1, Helsinki, Biomedicum 1
Thomas Helleday, PhD, Group Leader, Stockholm University and MRC Professor of Cancer Therapeutics, University of Oxford.
Thomas' research group is focused on exploring the cell and molecular biology of DNA damage responses in cancer as well as the preclinical process of translating these responses into clinical applications.
The title of his Special FIMM Seminar is: “Exploiting cancer defects for novel treatment of cancer”.